Health Care Sector CIGB-258 and Itolizumab Show Success in COVID-19 Treatment Two more drugs, CIGB-258 and Itolizumab (Anti-CD6), manufactured by the Center for Genetic Engineering and Biotechnology (CIGB) have been added to Cuba’s arsenal of... Cuba Business Report StaffMay 26, 2020